Navigation Links
Boehringer Ingelheim's Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3
Date:11/1/2010

formulary coverage and anticipate PRADAXA will be reimbursed at a co-pay level similar to other preferred branded products.  Programs that offer financial assistance to those who may otherwise be unable to afford medication also are available through the BI CARES Foundation. 

"Treatment with PRADAXA does not require routine blood monitoring or related dose adjustments.  In addition, there are no recommended dietary restrictions," said Christopher Corsico, M.D., MPH, medical director, Boehringer Ingelheim Pharmaceuticals, Inc.  "PRADAXA has the potential to significantly impact the treatment paradigm for patients with non-valvular atrial fibrillation.  We are working with insurers to make PRADAXA as affordable and accessible as possible."

PRADAXA 150mg taken twice daily has been shown to significantly reduce stroke and systemic embolism by 35 percent beyond the reduction achieved with warfarin,(1) the current standard of care for patients with non-valvular atrial fibrillation.  PRADAXA 150mg taken twice daily has been shown to significantly reduce both ischemic strokes (caused by blood clots) and hemorrhagic strokes (caused by bleeding) compared to warfarin. (1)  A 75mg twice daily dose of PRADAXA also is approved for the small subset of patients who have severe renal impairment. (1)  

About Atrial Fibrillation and Stroke

Atrial fibrillation (AFib), characterized by an irregular heartbeat,(2) can cause blood clots to form in the heart that can travel to the brain and cause a stroke.(2) An estimated 2.3 million Americans are living with AFib, (3) and the prevalence is expected to increase to 5.6 million by 2050.(3) A large managed care database study showed that non-valvular atrial fibrillation represents approximately 95 percent of all atrial fibrillation cases in the U.S. (3)  Atrial fibrillation increases the risk of stroke nearly five times (4)and is associat
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)...  IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey ... the first quarter ended March 31, 2015. First ... million in the first quarter of 2015, an increase of ... net revenues generated from the sale of IGI label generic ... 2015 and 2014 of $8.1 million, and $2.9 million, respectively ...
(Date:4/28/2015)... Mass. , April 28, 2015 Merrimack Pharmaceuticals, ... will hold its First Quarter 2015 Investor Conference Call and ... 2015.  Merrimack also announced it will present at the Credit ... 10:55 a.m., Eastern Time, in New York ... The call will cover an update on Merrimack,s ...
(Date:4/28/2015)... -- Perrigo Company plc (NYSE: PRGO ; TASE) today ... dividend of $0.125 per share, payable on June 16, 2015 ... From its beginnings as a packager of ... in Ireland , has grown to ... and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, ...
Breaking Medicine Technology:IGI Laboratories Announces First Quarter 2015 Results 2IGI Laboratories Announces First Quarter 2015 Results 3IGI Laboratories Announces First Quarter 2015 Results 4IGI Laboratories Announces First Quarter 2015 Results 5IGI Laboratories Announces First Quarter 2015 Results 6IGI Laboratories Announces First Quarter 2015 Results 7IGI Laboratories Announces First Quarter 2015 Results 8IGI Laboratories Announces First Quarter 2015 Results 9IGI Laboratories Announces First Quarter 2015 Results 10IGI Laboratories Announces First Quarter 2015 Results 11Merrimack Pharmaceuticals Announces Timing of First Quarter 2015 Investor Conference Call and Presentation at Credit Suisse 2015 Antibody Conference 2
... Transcript Pharmacy has been awarded accreditation status by the ... pharmacy services.   "This recognition demonstrates that ... offer bring significant benefits to the patients that we ... private, not-for-profit corporation which is certified to ISO 9001:2008 ...
... OAKS, Calif., Oct. 20 Amgen (Nasdaq: AMGN ... quarter financial results on Monday, Oct. 25, 2010 after the ... by a conference call with the investment community at 2 ... be Kevin Sharer, chairman and chief executive officer, and other ...
Cached Medicine Technology:Transcript Pharmacy Awarded Accreditation by ACHC 2Amgen Announces Webcast of 2010 Third Quarter Financial Results 2
(Date:4/28/2015)... (PRWEB) April 28, 2015 Aultman ... Care Advantage (WCA) to transition its outpatient wound ... the hospital’s commitment to the specialty of wound ... across the country currently working with Wound ... offers advanced wound care treatments and hyperbaric oxygen ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Children’s ... advances the cause of medical foods and formulas ... Childress as the organization’s new executive director. , ... severe health consequences because of conditions and diseases ... life-sustaining diet. To live and thrive, they ...
(Date:4/28/2015)... 2015 Market Research Report on Global ... in-depth research report. The report provides information such ... chain structure, international market analysis, and China’s domestic ... Europe, Japan, Asia) and Chinese market as well ... situation analysis. The Global and Chinese Centrifuges Industry ...
(Date:4/28/2015)... Vancouver personal injury lawyers at Jiwa Law Corporation ... to call an attorney before calling the ICBC in ... that there are several benefits of hiring a personal ... law and can help clients reach a better settlement ... own. Competent and experienced personal injury lawyers help their ...
(Date:4/28/2015)... MSA Executive Search , an INTEGRATED ... that it has been retained to lead a nationwide ... for The Queen's Health Systems (QHS) located in ... & CEO Arthur A. Ushijima, the Executive Vice President ... the Queen’s Medical Center Punchbowl and West O’ahu sites, ...
Breaking Medicine News(10 mins):Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 2Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 3Health News:Children's Medical Nutrition Alliance (CMNuA) Hires Kaycee Childress as Executive Director 2Health News:Centrifuges Market 2015 Global Research Report 2Health News:Centrifuges Market 2015 Global Research Report 3Health News:Vancouver Personal Injury Lawyers Recently Stated in Latest Blog That It Is Smarter To Call A Lawyer Before ICBC 2Health News:The Queen’s Health Systems Retains MSA Executive Search to Recruit Executive Vice President & Chief Operating Officer 2
... 10,000 pediatricians,and other health care professionals are expected to ... and Exhibition (NCE),at the Hynes Convention Center in Boston., ... 12, 11:50 a.m.-12:10 p.m., The ABC Ballroom at ... a huge recording studio as over 2,500,pediatricians get to ...
... WASHINGTON, Oct. 8 Give an Hour, a,non-partisan, ... veterans and their loved ones, announces a collaboration ... used by thousands,of consumers nationwide to locate needed ... agreement, mental health professionals, who join the Give,an ...
... Northwestern Memorial,s Bluhm Cardiovascular Institute is one of ... aimed at improving the heart,s pumping action and helping ... trial tests the effectiveness of placing a small device ... the heart. Northwestern Memorial physicians recently implanted the first ...
... 300 million cases of the disease each year , , WEDNESDAY, ... malaria-causing Plasmodium vivax parasite has been described by ... help in the fight against malaria. , The majority of ... parasite, which causes the most virulent form of the ...
... ALEXANDRIA, Va., Oct, 8 The National,Community Pharmacists ... one-term incumbent representing Minnesota, for re-election to the,U.S. ... CEO of NCPA,issued the following statement:, "Senator ... and,America,s community pharmacies and the patients they serve. ...
... The National,Community Pharmacists Association (NCPA) is endorsing Sen. ... re-election to the,U.S. Senate. Bruce Roberts, RPh, executive ... statement:, "Senator Richard Durbin is a powerful ... patients they serve. That is why the,National Community ...
Cached Medicine News:Health News:AAP National Conference and Exhibition October 10-14, 2008 2Health News:AAP National Conference and Exhibition October 10-14, 2008 3Health News:HelpPRO and Give an Hour Join to Help Military Families Get Free Therapy Services 2Health News:Northwestern Memorial trials implantable device to manage congestive heart failure symptoms 2Health News:Genetic Research Offers Insights Into Form of Malaria 2
... QuadraLase™ is a unique lateral ... that may be rotated to ... like having four fibers in ... used for vaporization and coagulation ...
... Graft with the H&L-B One-Shot Introduction System ... endovascular treatment of patients with abdominal aortic ... endovascular repair. The Zenith AAA Endovascular Graft ... to "seal off" the aneurysm. The graft ...
... The Ultrafin™ Stirrup is ... positioing. This stirrup features a ... and accommodates up to an ... technology helps to position heavy ...
Stirrups provide a safe system for positioning patients in a variety of lithotomy positions. Power-assisted positioning, as well as abduction, assures proper positioning of the patient. Includes one ...
Medicine Products: